John Wesolowski
Equibles does not estimate personal net worth.
Get an email with a short summary when Intensity Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INTS alertsAbout John Wesolowski
The proxy statement of Intensity Therapeutics, Inc. reports total compensation of $378,452 for John Wesolowski in fiscal 2025, including a base salary of $246,820. Disclosed compensation is on record for 4 fiscal years. Intensity Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intensity Therapeutics, Inc. includes Lewis H. Bender (CEO), Joseph Talamo (CFO), Daniel Donovan (Board Member) and 3 others.
Affiliation history
-
Intensity Therapeutics, Inc. (INTS)
Proxy statement
CurrentStart not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Intensity Therapeutics, Inc.
- Lewis H. Bender CEO
- Joseph Talamo CFO
- Daniel Donovan Board Member
- Emer Leahy Board Member
- Mark A. Goldberg Board Member
- Thomas I. H. Dubin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intensity Therapeutics, Inc. (INTS) | Principal Accounting Officer and Controller | $246,820 | $378,452 |
| 2024 | Intensity Therapeutics, Inc. (INTS) | Principal Accounting Officer and Controller | $251,347 | $569,129 |
| 2023 | Intensity Therapeutics, Inc. (INTS) | Principal Accounting Officer and Controller | $186,154 | $527,291 |
| 2022 | Intensity Therapeutics, Inc. (INTS) | Principal Accounting Officer and Controller | $165,000 | $251,157 |
Recent activity
No call appearances or filed executive changes recorded yet.